Possible pathogenetic relevance of interleukin-1β in "'destructive" organ-specific autoimmune disease (Hashimoto's thyroiditis)

被引:26
作者
Paolieri, F
Salmaso, C
Battifora, M
Montagna, P
Pesce, G
Bagnasco, M
Richiusa, P
Galluzzo, A
Giordano, C
机构
[1] Univ Genoa, Dept Internal Med, Allergy & Clin Immunol Serv, DIMI, I-16132 Genoa, Italy
[2] Univ Palermo, Inst Clin Med, Endocrinol Sect, Palermo, Italy
来源
NEUROENDOCRINE IMMUNE BASIS OF THE RHEUMATIC DISEASES | 1999年 / 876卷
关键词
D O I
10.1111/j.1749-6632.1999.tb07642.x
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Thyroid follicular cells (TFC) abundantly express a variety of immunologically relevant surface molecules in Hashimoto's thyroiditis (HT), for example, MHC antigens and adhesion molecules such as ICAM-1. Cytokines produced by infiltrating type 1 helper and cytotoxic: T cells are importantly involved in de novo expression or up-regulation of such molecules. We recently demonstrated that TFC from PIT patients almost invariably bear on their surface two additive functional molecules: Fas/Apo1/CD95, an important participant in apoptosis, and B7.1, a member of a family of "co-stimulatory" molecules that are crucial for efficient antigen presentation. To date, 12 out of 14 surgical HT thyroid specimens that ne studied by immunohistochemistry showed B7.1-positive TFC, and all showed Fas-positive TFC, different from Graves' disease (GD) or nonautoimmune specimens. We have investigated the role of a number of cytokines (IL-1 beta, TNF-alpha, IL-4, IL-6, IL-10, IL-12, TGF-beta 1, IFN-gamma) in regulating B7.1 and Fas expression. The experiments were performed by immunofluorescence flow cytometry on TFC purified from nontoxic goiter specimens which were Fas- and B7.1-negative at baseline, and one B7.1/Fas-positive HT specimen. IFN-gamma (500 U/mL) and TNF-alpha (200 ng/ml) were unable to induce de novo expression of B7.1 or Fas on cultured TFC. At higher doses (2000 U/mL and 800 ng/mL, respectively), they were unable to induce B7.1, but potentiated the spontaneous expression of Fas. Type 2 cytokines (IL-4 and IL-10) were unable to induce Fas or B7.1 on TFC at all, or to down-regulate Fas or B7.1 when expressed. On the other hand, IL-1 beta was the only cytokine able to induce Fas expression on Fas-negative TFC at doses ranging from 100 to 1000 pg/mL. Moreover, at a dose of 400 pg/mL, it mas also able to induce B7.1. We demonstrated by immunohistochemistry that IL-1 beta is abundantly present on HT thyroids, including follicular structures. It is conceivable that IFN-gamma, or other cytokines secreted by infiltrating T-lymphocytes, are able to promote IL-IB secretion by TFC. In conclusion, a crucial role of IL-1 beta in "destructive" organ specific autoimmunity may be suggested both for the perpetuation of the autoimmune reaction (induction of efficient autoantigen presentation by TFC, via co-stimulatory molecules) and in induction of tissue damage via "suicide" Fas/FasL-mediated TFC interaction.
引用
收藏
页码:221 / 228
页数:8
相关论文
共 12 条
[1]   FOLLICULAR THYROID-CELLS OF AUTOIMMUNE-THYROIDITIS MAY COEXPRESS ICAM-1 (CD54) AND ITS NATURAL LIGAND LFA-1 (CD11A/CD18) [J].
BAGNASCO, M ;
PESCE, GP ;
CARETTO, A ;
PAOLIERI, F ;
PRONZATO, C ;
VILLAGGIO, B ;
GIORDANO, C ;
BETTERLE, C ;
CANONICA, GW .
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 1995, 95 (05) :1036-1043
[2]  
Bagnasco M, 1996, FUND CLIN IMMUNOL, V4, P7
[3]   B7.1 costimulatory molecule is expressed on thyroid follicular cells in Hashimoto's thyroiditis, but not in Graves' disease [J].
Battifora, M ;
Pesce, G ;
Paolieri, F ;
Fiorino, N ;
Giordano, C ;
Riccio, AM ;
Torre, G ;
Olive, D ;
Bagnasco, M .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 1998, 83 (11) :4130-4139
[4]  
DELPRETE GF, 1987, CLIN EXP IMMUNOL, V69, P323
[5]   A license to kill [J].
Fraser, A ;
Evan, G .
CELL, 1996, 85 (06) :781-784
[6]   Potential involvement of fas and its ligand in the pathogenesis of Hashimoto's thyroiditis [J].
Giordano, C ;
Stassi, G ;
DeMaria, R ;
Todaro, M ;
Richiusa, P ;
Papoff, G ;
Ruberti, G ;
Bagnasco, M ;
Testi, R ;
Galluzzo, A .
SCIENCE, 1997, 275 (5302) :960-963
[7]   The role of FasL-induced apoptosis in immune privilege [J].
Griffith, TS ;
Ferguson, TA .
IMMUNOLOGY TODAY, 1997, 18 (05) :240-244
[8]  
HANAFUSA T, 1983, LANCET, V2, P1111
[9]   THE B7 AND CD28 RECEPTOR FAMILIES [J].
JUNE, CH ;
BLUESTONE, JA ;
NADLER, LM ;
THOMPSON, CB .
IMMUNOLOGY TODAY, 1994, 15 (07) :321-331
[10]   B7-1 AND B7-2 COSTIMULATORY MOLECULES ACTIVATE DIFFERENTIALLY THE TH1/TH2 DEVELOPMENTAL PATHWAYS - APPLICATION TO AUTOIMMUNE-DISEASE THERAPY [J].
KUCHROO, VK ;
DAS, MP ;
BROWN, JA ;
RANGER, AM ;
ZAMVIL, SS ;
SOBEL, RA ;
WEINER, HL ;
NABAVI, N ;
GLIMCHER, LH .
CELL, 1995, 80 (05) :707-718